A Multicenter, Prospective, Randomized Trial of Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Severity of adverse events as assessed by the WHO
It is difficult to estimate the exact cycles of chemotherapy,we may calculate the rate of complete response and the rate of treatment failure at the preliminary end point of the trail.
3 years
Yes
Xing Xie, MD, PhD
Study Chair
Zhejiang University
China: Ministry of Health
2012-GYN/GTN-01
NCT01823315
December 2012
December 2017
Name | Location |
---|